A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

Dean A. Regier, Samantha Pollard, Melanie McPhail, Tania Bubela, Timothy P. Hanna, Cheryl Ho, Howard J. Lim, Kelvin Chan, Stuart J. Peacock, Deirdre Weymann

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Abstract

Health technology assessment (HTA) can be used to make healthcare systems more equitable and efficient. Advances in precision oncology are challenging conventional thinking about HTA. Precision oncology advances are rapid, involve small patient groups, and are frequently evaluated without a randomized comparison group. In light of these challenges, mechanisms to manage precision oncology uncertainties are critical. We propose a life-cycle HTA framework and outline supporting criteria to manage uncertainties based on real world data collected from learning healthcare systems. If appropriately designed, we argue that life-cycle HTA is the driver of real world evidence generation and furthers our understanding of comparative effectiveness and value. We conclude that life-cycle HTA deliberation processes must be embedded into healthcare systems for an agile response to the constantly changing landscape of precision oncology innovation. We encourage further research outlining the core requirements, infrastructure, and checklists needed to achieve the goal of learning healthcare supporting life-cycle HTA.

Original languageEnglish
Article number76
Journalnpj Precision Oncology
Volume6
Issue number1
DOIs
Publication statusPublished - Dec 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada'. Together they form a unique fingerprint.

Cite this